By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix reported after the close of the market Wednesday that its third-quarter revenues increased 68 percent on an 82 percent rise in diagnostic testing revenue.

The Irvine, Calif.-based firm brought in total revenues of $1 million for the three-month period ended Sept. 30, compared to $603,000 for the third quarter of 2009. Its services revenue for the quarter rose to $924,000 from $507,000 year over year, while product revenue declined to $90,000 from $96,000.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.

Dec
11
Sponsored by
PerkinElmer

This webinar describes a study that used two independent next-generation sequencing (NGS) platforms to gain insight into the impact of different types of aneuploidies during preimplantation genetic testing.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.